News for 'drug manufacturing'

Hashish oil worth Rs 225 cr seized in Odisha's Koraput

Hashish oil worth Rs 225 cr seized in Odisha's Koraput

Rediff.com27 Feb 2026

Police in Odisha's Koraput district seized hashish oil worth approximately 225 crore from a forest manufacturing unit. Over 1,800 litres of hashish oil were recovered, and equipment was confiscated. In a separate operation, 1,143 kg of ganja worth 5 crore was seized, leading to four arrests.

Police seize drugs worth Rs 37 cr, bust manufacturing unit near Mumbai; 7 held

Police seize drugs worth Rs 37 cr, bust manufacturing unit near Mumbai; 7 held

Rediff.com24 Oct 2023

Liquid and powder raw materials worth Rs 2.73 lakh, chemicals worth Rs 2.59 lakh, besides vehicles, two country-made pistols, four magazines, and 14 cartridges were seized from seven accused, he said.

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Rediff.com11 Mar 2026

For decades, multinational pharmaceutical companies and Indian drugmakers worked in ways that supported each other: MNCs brought innovation and brands, while Indian companies built scale through generics and cost efficiency. There was an important overlap - generic drugs - but this is shrinking fast. And the consequences are reshaping India's gigantic pharmaceutical market.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

Govt Bans Sale Of Oral Nimesulide

Govt Bans Sale Of Oral Nimesulide

Rediff.com2 Jan 2026

The Union health ministry has banned the manufacture, sale and distribution of all oral formulations containing the popular painkiller nimesulide above 100 milligrams for human use, citing health risks.

Interstate Narcotics Syndicate Busted in Delhi, Three Arrested

Interstate Narcotics Syndicate Busted in Delhi, Three Arrested

Rediff.com10 Mar 2026

Delhi Police have arrested three individuals and seized over one kilogram of heroin, valued at 2 crore, dismantling an interstate narcotics syndicate operating between Uttar Pradesh and Delhi.

Cough syrup deaths: Many states ban Coldrif; MP suspends officials

Cough syrup deaths: Many states ban Coldrif; MP suspends officials

Rediff.com7 Oct 2025

A special investigation team (SIT) has been formed in Madhya Pradesh to investigate the deaths of 14 children in Chhindwara, suspected to be linked to a toxic cough syrup. The investigation includes arrests, exhumations, and a ban on the implicated cough syrup.

SIT to Investigate Illegal Hashish Oil Trade in Odisha

SIT to Investigate Illegal Hashish Oil Trade in Odisha

Rediff.com28 Feb 2026

Odisha Police formed a Special Investigation Team (SIT) to investigate an illegal hashish oil trade operating from an island in Koraput district, following a major drug seizure and multiple arrests.

Coldrif syrup maker used industrial-grade materials: ED

Coldrif syrup maker used industrial-grade materials: ED

Rediff.com3 Dec 2025

An Enforcement Directorate (ED) probe has revealed that the manufacturer of Coldrif syrup, linked to the deaths of at least 20 children in Madhya Pradesh, used industrial-grade raw materials without quality checks. The investigation also found that Tamil Nadu Drugs Control Department officials were in frequent contact with the company but failed to conduct mandated inspections.

Indian pharma to get stronger dose of EU mkt access

Indian pharma to get stronger dose of EU mkt access

Rediff.com5 Feb 2026

The European Union's (EU's) offer to slash tariffs on 97.5 per cent of Indian chemical exports to zero is set to give India's pharmaceutical and medical device firms preferential access to the European markets.

HC quashes licence cancellation of drug firm linked to Uzbek deaths

HC quashes licence cancellation of drug firm linked to Uzbek deaths

Rediff.com15 Jun 2025

Justice Dinesh Pathak, allowing a writ petition filed by M/s Marion Biotech Private Limited, observed that he was surprised that Indian authorities are "trying to validate their proceedings" based on the judgement of the Supreme Court of the Republic of Uzbekistan.

Highlights of Union Budget 2026-27

Highlights of Union Budget 2026-27

Rediff.com1 Feb 2026

Highlights of Union Budget 2026-27

DRI busts drug unit in Maha city, seizes drugs worth Rs 160 cr

DRI busts drug unit in Maha city, seizes drugs worth Rs 160 cr

Rediff.com29 Oct 2023

Search of two premises of a firm called Apex Medichem Private Limited on Saturday led to the seizures, he said.

Gulf War: Stocks That Could Buck The Trend And Shine

Gulf War: Stocks That Could Buck The Trend And Shine

Rediff.com14 Apr 2026

10 stocks from the Nifty 200 index that offer good growth potential and scope to deliver decent returns from current levels, based on brokerage estimates.

Is Pharmaceutical Engg Better Than BPham And PharmD?

Is Pharmaceutical Engg Better Than BPham And PharmD?

Rediff.com11 Nov 2025

rediffGURU Nayagam PP advises young aspirants how to pick the right course and career.

NVIDIA CEO: AI Driving Trillion-Dollar Infrastructure Boom and Blue-Collar Job Creation

NVIDIA CEO: AI Driving Trillion-Dollar Infrastructure Boom and Blue-Collar Job Creation

Rediff.com11 Mar 2026

NVIDIA CEO Jensen Huang argues that Artificial Intelligence is driving the largest infrastructure buildout in human history, requiring trillions of dollars in investment and creating significant demand for skilled blue-collar labour.

Dr Reddy's profit down 14% on low Lenalidomide US sales

Dr Reddy's profit down 14% on low Lenalidomide US sales

Rediff.com22 Jan 2026

Pharma major Dr Reddy's Laboratories (DRL) reported a 14 per cent year-on-year (Y-o-Y) drop in consolidated net profit to Rs 1,210 crore in the December quarter of FY 2025-26 (Q3FY26) on low sales of cancer drug Lenalidomide in the North American market. The firm's revenue from operations grew to Rs 8,727 crore in Q3FY26, a 4.4 per cent Y-o-Y increase from Rs 8,357 crore recorded for the same quarter last year.

Delhi court acquits Brazilian in cocaine case, slams probe lapses

Delhi court acquits Brazilian in cocaine case, slams probe lapses

Rediff.com20 Feb 2026

A Delhi court acquitted a Brazilian national in a 2016 cocaine seizure case, citing the prosecution's failure to comply with mandatory provisions of the NDPS Act.

Healthcare Funds: Caution Advised

Healthcare Funds: Caution Advised

Rediff.com12 Feb 2026

Most first-time investors may be better served by diversified options such as flexicap or multi-cap funds, which already hold pharma and healthcare stocks.

Earnings upgrade to downgrade ratio improved after Q3

Earnings upgrade to downgrade ratio improved after Q3

Rediff.com3 Apr 2026

There are hopes of a turnaround in overall corporate earnings after six quarters of single digit growth.

Centre Proposes Stricter Cough Syrup Rules

Centre Proposes Stricter Cough Syrup Rules

Rediff.com1 Jan 2026

Following the death of 22 children due to consumption of contaminated cough syrups in Madhya Pradesh three months ago, the Union health ministry has proposed amendments in the country's drug rules to ensure a tougher criterion for their over-the-counter (OTC) sales in India.

New launches to keep growth momentum healthy for Sun Pharma stock

New launches to keep growth momentum healthy for Sun Pharma stock

Rediff.com13 Feb 2026

A strong third-quarter (October-December/Q3) performance for 2025-26 (FY26) has helped the stock of India's largest listed pharmaceutical (pharma) company, Sun Pharmaceutical Industries, gain about 7 per cent since the start of February.

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Rediff.com1 Feb 2026

Budget 2026 sticks to fiscal discipline, shuns populist measures despite five key state elections coming up, but ends up rattling stock markets with a higher transaction tax on derivatives trading.

Govt launches all India drive to test cough syrups

Govt launches all India drive to test cough syrups

Rediff.com9 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) has initiated a nationwide campaign to test, inspect, and audit cough syrup manufacturers following concerns about contaminated products and child deaths. The initiative aims to ensure adherence to safety standards and regulatory compliance.

Cough syrup deaths: No state follows pharma safety norms

Cough syrup deaths: No state follows pharma safety norms

Rediff.com10 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers.

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Rediff.com14 May 2025

A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies, while sparing the Indian generic drug makers in the short term. US President Donald Trump signed the EO on Monday, directing the US Trade Representative and the Secretary of Commerce to act against foreign countries that "purposefully and unfairly undercut market prices", driving price hikes in the US.

Centre Moves To Bar Drugmakers Over Fake Information

Centre Moves To Bar Drugmakers Over Fake Information

Rediff.com3 Nov 2025

At present, there is no provision under Drugs Rules, 1945 to address issues of wrong information to obtain regulatory approvals.

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

3 cough syrups have been recalled: India replies to WHO

3 cough syrups have been recalled: India replies to WHO

Rediff.com9 Oct 2025

India's drug regulator CDSCO has recalled three cough syrups and halted their production after the WHO raised concerns about potential contamination and links to child deaths. The WHO is investigating reports of pediatric illnesses and deaths in India potentially linked to contaminated syrups.

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

US tariffs: Only Sun Pharma exposed to some headline risk

US tariffs: Only Sun Pharma exposed to some headline risk

Rediff.com28 Sep 2025

The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not significantly hurt Indian drug makers, with Sun Pharma being exposed to some headline risk but with limited earnings impact, according to analysts. Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US (about 17 per cent of 2024-25 revenue), HSBC Global Investment Research said in a report.

Cough syrup kills 14 children in MP, doctor arrested

Cough syrup kills 14 children in MP, doctor arrested

Rediff.com5 Oct 2025

Police have arrested a doctor for alleged negligence and registered a case against the manufacturer of a 'toxic' cough syrup after the death of 14 children in Chhindwara due to suspected renal failure, officials said on Sunday.

Was killer cough syrup exported, asks WHO to India

Was killer cough syrup exported, asks WHO to India

Rediff.com9 Oct 2025

The WHO will take a call on issuing a 'Global Medical Products Alert' on the cough syrup, Coldrif, after receiving an official confirmation from authorities here. The agency issues such alerts for substandard and contaminated medicines.

618 Drugs 'Not Of Standard Quality'

618 Drugs 'Not Of Standard Quality'

Rediff.com9 Dec 2024

Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid. Medications using these combinations are commonly used to treat fever, mild migraine, period and muscle pain.

UP cracks down on illegal cough syrup trade, 75 arrested

UP cracks down on illegal cough syrup trade, 75 arrested

Rediff.com20 Dec 2025

Uttar Pradesh authorities have registered 74 cases and arrested 75 people in connection with the illegal storage and sale of codeine-based cough syrup. A minister alleges links to the Samajwadi Party and an SIT is investigating.

Kingpin in Rs 252-cr meow-meow haul nabbed after Dubai deportation

Kingpin in Rs 252-cr meow-meow haul nabbed after Dubai deportation

Rediff.com23 Oct 2025

Mumbai police have arrested Mohammed Salim Mohammed Suhail Shaikh, a key accused in a Rs 252-crore mephedrone seizure case, after his deportation from Dubai. Shaikh, known as 'Lavish,' is a member of an international drug syndicate and managed the supply and distribution chain from Dubai.

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Rediff.com8 Oct 2025

Madhya Pradesh Deputy Chief Minister Rajendra Shukla confirmed that 20 children have died after consuming contaminated cough syrup. An investigation is underway, and action has been taken against the manufacturer, doctor, and FDA officials.

Import duties on 25 critical minerals, 36 drugs removed

Import duties on 25 critical minerals, 36 drugs removed

Rediff.com1 Feb 2025

Finance Minister Nirmala Sitharaman on Saturday announced the removal of import duties on 12 critical minerals, lithium-ion batteries scrap, cobalt products, LED, zinc and 36 drugs for cancer and rare diseases.

13 arrested from Gujarat, Rajasthan with drugs worth Rs 230 cr

13 arrested from Gujarat, Rajasthan with drugs worth Rs 230 cr

Rediff.com28 Apr 2024

The raids were conducted by the Gujarat Anti Terrorist Squad and Narcotics Control Bureau jointly on Friday after the ATS received a tip-off that Ahmedabad resident Manoharlal Enani and Kuldeepsinh Rajpurohit of Rajasthan had set up mephedrone manufacturing units, the official said on Saturday.

India launches nationwide HPV vaccination drive

India launches nationwide HPV vaccination drive

Rediff.com24 Feb 2026

The Indian government is set to launch a nationwide HPV vaccination program targeting 14-year-old girls to prevent cervical cancer, utilizing a single-dose vaccine and aiming for equitable access across socio-economic groups.